Studying the coagulopathy of COVID-19

por Spyropoulos, Alex C, Bonaca, Marc P
Publicado 2022

What Is the Evidence of the Diagnostic Criteria and Screening of Immune Checkpoint Inhibitor–Induced Myocarditis?

por Thuny, Franck, Bonaca, Marc P., Cautela, Jennifer
Publicado 2022

Burden of Cardiovascular Disease in Immune Checkpoint Inhibitor–Treated Patients: Reconciling Adjudicated and Coded Outcomes

por Kondapalli, Lavanya, Hsia, Judith, Miller, Ronni, Flaig, Thomas W., Bonaca, Marc P.
Publicado 2022

At-home sample collection is an effective strategy for diagnosis and management of symptomatic and asymptomatic SARS-CoV-2 carriers

por Humphreys, Devon P., Gavin, Kathleen M., Olds, Kaylan M., Bonaca, Marc P., Bauer, Timothy A.
Publicado 2022

International Perspectives on the Impact of the COVID-19 Pandemic on Adherence to Prescribed Dual Antiplatelet Therapy: A Window Into Acute Cardiovascular Care

por Pollack, Charles V., Steg, P. Gabriel, James, Stefan, Jolly, Sanjit, Kosiborod, Mikhail, Bonaca, Marc P.
Publicado 2022

Randomized, Controlled Trial of a Digital Behavioral Therapeutic Application to Improve Glycemic Control in Adults With Type 2 Diabetes

por Hsia, Judith, Guthrie, Nicole L., Lupinacci, Paul, Gubbi, Ananda, Denham, Douglas, Berman, Mark A., Bonaca, Marc P.
Publicado 2022

Impact of transitioning to virtual delivery of a cardiovascular health improvement program for Latinos during the COVID-19 pandemic

por Iglesias, Amelia, Ambrose, Ashley, Coronel-Mockler, Stephanie, Kilbourn, Kristin, Bonaca, Marc P., Estacio, Raymond O., Krantz, Mori J.
Publicado 2022

THU254 VICTOR-Pilot Study Of A Virtual Dietary Intervention To Improve Diabetes And Cardiovascular Risk In Rural Communities - Primary Results

por Low Wang, Cecilia C, Estacio, Raymond O, Coronel-Mockler, Stephanie, Flattery, Nick, McKenzie, Amy, Harrison, David, Bonaca, Marc P
Publicado 2023

Left Ventricular Ejection Fraction in Patients With Ovarian Cancer Treated With Avelumab, Pegylated Liposomal Doxorubicin, or Both

por Bonaca, Marc P, Moslehi, Javid J, Ledermann, Jonathan A, Michelon, Elisabete, Wei, Caimiao, Moran, Michael, Monk, Bradley J, Pujade-Lauraine, Eric
Publicado 2023

Efficacy and Safety of Vorapaxar by Intensity of Background Lipid‐Lowering Therapy in Patients With Peripheral Artery Disease: Insights From the TRA2P‐TIMI 50 Trial

por Gilchrist, Ian C., Morrow, David A., Creager, Mark A., Olin, Jeffrey W., Scirica, Benjamin M., Goodrich, Erica L., Bonaca, Marc P.
Publicado 2021

Pharmacokinetic–pharmacodynamic modelling of platelet response to ticagrelor in stable coronary artery disease and prior myocardial infarction patients

por Åstrand, Magnus, Amilon, Carl, Röshammar, Daniel, Himmelmann, Anders, Angiolillo, Dominick J., Storey, Robert F., Gurbel, Paul A., Bonaca, Marc P., Hamrén, Bengt
Publicado 2018

Exercise Training and Revascularization in the Management of Symptomatic Peripheral Artery Disease

por Biswas, Minakshi P., Capell, Warren H., McDermott, Mary M., Jacobs, Donald L., Beckman, Joshua A., Bonaca, Marc P., Hiatt, William R.
Publicado 2021

Cardiovascular Biomarkers and Heart Failure Risk in Stable Patients With Atherothrombotic Disease: A Nested Biomarker Study From TRA 2°P‐TIMI 50

por Berg, David D., Freedman, Benjamin L., Bonaca, Marc P., Jarolim, Petr, Scirica, Benjamin M., Goodrich, Erica L., Sabatine, Marc S., Morrow, David A.
Publicado 2021

Cardiovascular efficacy of liraglutide and semaglutide in individuals with diabetes and peripheral artery disease

por Verma, Subodh, Al‐Omran, Mohammed, Leiter, Lawrence A., Mazer, C. David, Rasmussen, Søren, Saevereid, Hans A., Sejersten Ripa, Maria, Bonaca, Marc P.
Publicado 2022

Response to Mei et al. regarding the incidence and predictors of hospitalization for heart failure among patients with stable atherosclerosis in the TRA 2°P‐TIMI 50 trial

por Freedman, Benjamin L., Berg, David D., Scirica, Benjamin M., Bohula, Erin A., Goodrich, Erica L., Sabatine, Marc S., Morrow, David A., Bonaca, Marc P.
Publicado 2023

Epidemiology of heart failure hospitalization in patients with stable atherothrombotic disease: Insights from the TRA 2°P‐TIMI 50 trial

por Freedman, Benjamin L., Berg, David D., Scirica, Benjamin M., Bohula, Erin A., Goodrich, Erica L., Sabatine, Marc S., Morrow, David A., Bonaca, Marc P.
Publicado 2022

Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes

por Røysland, Ragnhild, Bonaca, Marc P, Omland, Torbjørn, Sabatine, Marc, Murphy, Sabina A, Scirica, Benjamin M, Bjerre, Mette, Flyvbjerg, Allan, Braunwald, Eugene, Morrow, David A
Publicado 2012

Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial

por Piazza, Gregory, Spyropoulos, Alex C., Hsia, Judith, Goldin, Mark, Towner, William J., Go, Alan S., Bull, Todd M., Weng, Stephen, Lipardi, Concetta, Barnathan, Elliot S., Bonaca, Marc P.
Publicado 2023

How does the TRS 2°P score relate to real-world patients?

por Bonaca, Marc P, De Ferrari, Gaetano M, Atar, Dan, Bash, Lori D, Lautsch, Dominik, Bohula, Erin A, Horack, Martin, Brudi, Philippe, Ferrieres, Jean, Gitt, Anselm K
Publicado 2018

Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a “CASPAR like” outcome from VOYAGER PAD

por Bonaca, Marc P., Szarek, Michael, Debus, E. Sebastian, Nehler, Mark R., Patel, Manesh R., Anand, Sonia S., Muehlhofer, Eva, Berkowitz, Scott D., Haskell, Lloyd P., Bauersachs, Rupert M.
Publicado 2022